The complex mechanism of antimycobacterial action of 5-fluorouracil. 2015

Vinayak Singh, and Miroslav Brecik, and Raju Mukherjee, and Joanna C Evans, and Zuzana Svetlíková, and Jaroslav Blaško, and Sachin Surade, and Jonathan Blackburn, and Digby F Warner, and Katarína Mikušová, and Valerie Mizrahi
MRC/NHLS/UCT Molecular Mycobacteriology Research Unit & DST/NRF Centre of Excellence for Biomedical TB Research, Institute of Infectious Disease and Molecular Medicine and Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory 7925, Rondebosch, Cape Town 7700, South Africa.

A combination of chemical genetic and biochemical assays was applied to investigate the mechanism of action of the anticancer drug 5-fluorouracil (5-FU), against Mycobacterium tuberculosis (Mtb). 5-FU resistance was associated with mutations in upp or pyrR. Upp-catalyzed conversion of 5-FU to FUMP was shown to constitute the first step in the mechanism of action, and resistance conferred by nonsynonymous SNPs in pyrR shown to be due to derepression of the pyr operon and rescue from the toxic effects of FUMP and downstream antimetabolites through de novo production of UMP. 5-FU-derived metabolites identified in Mtb were consistent with the observed incorporation of 5-FU into RNA and DNA and the reduced amount of mycolyl arabinogalactan peptidoglycan in 5-FU-treated cells. Conditional depletion of the essential thymidylate synthase ThyX resulted in modest hypersensitivity to 5-FU, implicating inhibition of ThyX by fluorodeoxyuridylate as a further component of the mechanism of antimycobacterial action of this drug.

UI MeSH Term Description Entries
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009876 Operon In bacteria, a group of metabolically related genes, with a common promoter, whose transcription into a single polycistronic MESSENGER RNA is under the control of an OPERATOR REGION. Operons
D010430 Pentosyltransferases Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another.
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU

Related Publications

Vinayak Singh, and Miroslav Brecik, and Raju Mukherjee, and Joanna C Evans, and Zuzana Svetlíková, and Jaroslav Blaško, and Sachin Surade, and Jonathan Blackburn, and Digby F Warner, and Katarína Mikušová, and Valerie Mizrahi
January 1980, Doklady Akademii nauk SSSR,
Vinayak Singh, and Miroslav Brecik, and Raju Mukherjee, and Joanna C Evans, and Zuzana Svetlíková, and Jaroslav Blaško, and Sachin Surade, and Jonathan Blackburn, and Digby F Warner, and Katarína Mikušová, and Valerie Mizrahi
January 1990, Pharmacology & therapeutics,
Vinayak Singh, and Miroslav Brecik, and Raju Mukherjee, and Joanna C Evans, and Zuzana Svetlíková, and Jaroslav Blaško, and Sachin Surade, and Jonathan Blackburn, and Digby F Warner, and Katarína Mikušová, and Valerie Mizrahi
January 1993, Advances in experimental medicine and biology,
Vinayak Singh, and Miroslav Brecik, and Raju Mukherjee, and Joanna C Evans, and Zuzana Svetlíková, and Jaroslav Blaško, and Sachin Surade, and Jonathan Blackburn, and Digby F Warner, and Katarína Mikušová, and Valerie Mizrahi
October 1968, Cancer research,
Vinayak Singh, and Miroslav Brecik, and Raju Mukherjee, and Joanna C Evans, and Zuzana Svetlíková, and Jaroslav Blaško, and Sachin Surade, and Jonathan Blackburn, and Digby F Warner, and Katarína Mikušová, and Valerie Mizrahi
May 2021, Microorganisms,
Vinayak Singh, and Miroslav Brecik, and Raju Mukherjee, and Joanna C Evans, and Zuzana Svetlíková, and Jaroslav Blaško, and Sachin Surade, and Jonathan Blackburn, and Digby F Warner, and Katarína Mikušová, and Valerie Mizrahi
March 2008, Antimicrobial agents and chemotherapy,
Vinayak Singh, and Miroslav Brecik, and Raju Mukherjee, and Joanna C Evans, and Zuzana Svetlíková, and Jaroslav Blaško, and Sachin Surade, and Jonathan Blackburn, and Digby F Warner, and Katarína Mikušová, and Valerie Mizrahi
April 1994, The Journal of pharmacology and experimental therapeutics,
Vinayak Singh, and Miroslav Brecik, and Raju Mukherjee, and Joanna C Evans, and Zuzana Svetlíková, and Jaroslav Blaško, and Sachin Surade, and Jonathan Blackburn, and Digby F Warner, and Katarína Mikušová, and Valerie Mizrahi
June 1997, Biochemical pharmacology,
Vinayak Singh, and Miroslav Brecik, and Raju Mukherjee, and Joanna C Evans, and Zuzana Svetlíková, and Jaroslav Blaško, and Sachin Surade, and Jonathan Blackburn, and Digby F Warner, and Katarína Mikušová, and Valerie Mizrahi
August 1980, Journal of pharmacobio-dynamics,
Vinayak Singh, and Miroslav Brecik, and Raju Mukherjee, and Joanna C Evans, and Zuzana Svetlíková, and Jaroslav Blaško, and Sachin Surade, and Jonathan Blackburn, and Digby F Warner, and Katarína Mikušová, and Valerie Mizrahi
July 1995, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!